30 results
Keyword Alymsys Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Alymsys
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 26/03/2021,
, 
, Revision: 4, Authorised, Last updated: 15/12/2022
Alymsys Cancer Neoplasms Rectal … Alymsys … EMA/64590/2021 EMEA/H/C/005286 Alymsys (bevacizumab) An overview … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 25-29 January 2021
CHMP, Last updated: 01/02/2021Alymsys … -
List item
Human medicine European public assessment report (EPAR): Oyavas
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 26/03/2021,, , Revision: 4, Authorised, Last updated: 05/01/2023
-
List item
List of medicines under additional monitoring (updated)
Last updated: 27/03/2023 -
List item
Exemptions to labelling and package-leaflet obligations
Last updated: 11/01/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 20/02/2023 to 23/02/2023, Last updated: 20/02/2023 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 27/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 18/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 16/03/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2022
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2022 to 22/04/2022, Last updated: 12/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 22/02/2021 to 25/02/2021, Last updated: 07/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 12/08/2022 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 17/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 25-29 January 2021
Virtual meeting, from 25/01/2021 to 29/01/2021, Last updated: 04/03/2021 -
List item
Newsletters (updated)
Last updated: 27/03/2023 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
PRAC, Last updated: 30/09/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2021
Written procedure, from 16/08/2021 to 19/08/2021, Last updated: 04/11/2019 -
List item
News: Human medicines: highlights of 2021
Last updated: 15/02/2022Accord Abiraterone Krka Abiraterone Mylan Alymsys Gavreto Imatinib Koanaa Jemperli Lextemy* Lumykras Nexpovio Oyavas Padcev Pemazyre Qinlock Rybrevant Tepmetko Trodelvy Voraxaze Medicines that contain a new active substance are highlighted in bold BroPair … -
List item
EMA event supporting materials
Last updated: 14/06/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 13-16 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/09/2021 to 16/09/2021, Last updated: 04/11/2019 -
List item
Committee for Medicinal Products for Human Use (CHMP): 13-16 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 13/12/2021 to 16/12/2021, Last updated: 04/11/2019 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/02/2022 to 24/02/2022, Last updated: 06/04/2021